These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9820514)

  • 21. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls.
    Ott PA; Herzog BA; Quast S; Hofstetter HH; Boehm BO; Tary-Lehmann M; Durinovic-Bello I; Berner BR; Lehmann PV
    Clin Immunol; 2005 Apr; 115(1):102-14. PubMed ID: 15870028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infectious Th1 and Th2 autoimmunity in diabetes-prone mice.
    Tian J; Olcott AP; Hanssen LR; Zekzer D; Middleton B; Kaufman DL
    Immunol Rev; 1998 Aug; 164():119-27. PubMed ID: 9795770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells.
    Araujo LM; Lefort J; Nahori MA; Diem S; Zhu R; Dy M; Leite-de-Moraes MC; Bach JF; Vargaftig BB; Herbelin A
    Eur J Immunol; 2004 Feb; 34(2):327-35. PubMed ID: 14768037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
    Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
    Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
    Joussemet B; Vu AT; Sai P; Bach JM
    Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
    Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
    J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
    Li AF; Hough J; Henderson D; Escher A
    Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
    Tian J; Atkinson MA; Clare-Salzler M; Herschenfeld A; Forsthuber T; Lehmann PV; Kaufman DL
    J Exp Med; 1996 Apr; 183(4):1561-7. PubMed ID: 8666914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides.
    Wang H; Yang J; Jin L; Feng J; Lu Y; Sun Y; Li T; Cao R; Wu J; Fan H; Liu J
    Immunol Invest; 2009; 38(8):690-703. PubMed ID: 19860582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens.
    Elias D; Meilin A; Ablamunits V; Birk OS; Carmi P; Könen-Waisman S; Cohen IR
    Diabetes; 1997 May; 46(5):758-64. PubMed ID: 9133541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice.
    Tian J; Clare-Salzler M; Herschenfeld A; Middleton B; Newman D; Mueller R; Arita S; Evans C; Atkinson MA; Mullen Y; Sarvetnick N; Tobin AJ; Lehmann PV; Kaufman DL
    Nat Med; 1996 Dec; 2(12):1348-53. PubMed ID: 8946834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The frequency of high avidity T cells determines the hierarchy of determinant spreading.
    Tian J; Gregori S; Adorini L; Kaufman DL
    J Immunol; 2001 Jun; 166(12):7144-50. PubMed ID: 11390460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide.
    Elias D; Tikochinski Y; Frankel G; Cohen IR
    Int Immunol; 1999 Jun; 11(6):957-66. PubMed ID: 10360970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype.
    King C; Davies J; Mueller R; Lee MS; Krahl T; Yeung B; O'Connor E; Sarvetnick N
    Immunity; 1998 May; 8(5):601-13. PubMed ID: 9620681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice.
    Tian J; Zekzer D; Lu Y; Dang H; Kaufman DL
    J Immunol; 2006 Feb; 176(4):2654-61. PubMed ID: 16456028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific antigen vaccination to treat autoimmune disease.
    McDevitt H
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14627-30. PubMed ID: 15466699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.